142 related articles for article (PubMed ID: 3553005)
1. Induction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrier.
Jolivet ME; Audibert FM; Gras-Masse H; Tartar AL; Schlesinger DH; Wirtz R; Chedid LA
Infect Immun; 1987 Jun; 55(6):1498-502. PubMed ID: 3553005
[TBL] [Abstract][Full Text] [Related]
2. Production of antibodies recognizing a hepatitis B virus (HBV) surface antigen by administration of murabutide associated to a synthetic pre-S HBV peptide conjugated to a toxoid carrier.
Przewlocki G; Audibert F; Jolivet M; Chedid L; Kent SB; Neurath AR
Biochem Biophys Res Commun; 1986 Oct; 140(2):557-64. PubMed ID: 3778467
[TBL] [Abstract][Full Text] [Related]
3. Biologically active antibodies elicited by a synthetic circumsporozoite peptide of Plasmodium knowlesi administered in saline with a muramyl dipeptide derivative.
Clough ER; Audibert FM; Barnwell JW; Schlesinger DH; Arnon R; Chedid LA
Infect Immun; 1985 Jun; 48(3):839-42. PubMed ID: 3997250
[TBL] [Abstract][Full Text] [Related]
4. Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments.
Dale JB
Vaccine; 1999 Jan; 17(2):193-200. PubMed ID: 9987154
[TBL] [Abstract][Full Text] [Related]
5. Polyvalent synthetic vaccines: relationship between T epitopes and immunogenicity.
Jolivet M; Lise L; Gras-Masse H; Tartar A; Audibert F; Chedid L
Vaccine; 1990 Feb; 8(1):35-40. PubMed ID: 1690488
[TBL] [Abstract][Full Text] [Related]
6. Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens.
Audibert FM; Przewlocki G; Leclerc CD; Jolivet ME; Gras-Masse HS; Tartar AL; Chedid LA
Infect Immun; 1984 Jul; 45(1):261-6. PubMed ID: 6735468
[TBL] [Abstract][Full Text] [Related]
7. Production of anti-sporozoite antibodies in absence of response to carrier by coupling an MDP derivative to a malaria peptide-tetanus toxoid conjugate.
Clough ER; Jolivet M; Audibert F; Barnwell JW; Schlesinger DH; Chedid L
Biochem Biophys Res Commun; 1985 Aug; 131(1):70-6. PubMed ID: 4038309
[TBL] [Abstract][Full Text] [Related]
8. Role of muramyl peptides for the enhancement of synthetic vaccines.
Chedid L; Audibert F; Jolivet M
Dev Biol Stand; 1986; 63():133-40. PubMed ID: 3527818
[TBL] [Abstract][Full Text] [Related]
9. [Use of muramyl dipeptides in models of synthetic vaccines].
Audibert F
Boll Ist Sieroter Milan; 1985; 64(2):95-102. PubMed ID: 3896261
[TBL] [Abstract][Full Text] [Related]
10. Immunization of owl monkeys with the ring-infected erythrocyte surface antigen of Plasmodium falciparum.
Collins WE; Anders RF; Ruebush TK; Kemp DJ; Woodrow GC; Campbell GH; Brown GV; Irving DO; Goss N; Filipski VK
Am J Trop Med Hyg; 1991 Jan; 44(1):34-41. PubMed ID: 1996739
[TBL] [Abstract][Full Text] [Related]
11. [Enhancement of the activity of hepatitis B virus vaccine by association with murabutide].
Audibert F; Przewlocki G; Lefrancier P; Choay J; Chedid L
C R Seances Acad Sci III; 1982 Nov; 295(10):611-4. PubMed ID: 6218866
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antibody avidity and titre elicited by peptide as a protein conjugate or as expressed in vaccinia.
Lew AM; Anders RF; Edwards SJ; Langford CJ
Immunology; 1988 Oct; 65(2):311-4. PubMed ID: 3056855
[TBL] [Abstract][Full Text] [Related]
13. [The enhancement of the immunogenicity of streptococcal group-A M protein by conjugation with a synthetic polyelectrolyte].
Semenova EN; Sanina VIu; Nekrasov AV; Puchkova NG; Liampert IM
Zh Mikrobiol Epidemiol Immunobiol; 1991 Nov; (11):56-9. PubMed ID: 1725839
[TBL] [Abstract][Full Text] [Related]
14. Antibody responses elicited by a polyvalent vaccine containing synthetic diphtheric, streptococcal and hepatitis peptides coupled to the same carrier.
Chedid L; Jolivet M; Audibert F; Przewlocki G; Beachey EH; Gras-Masse H; Tartar A
Biochem Biophys Res Commun; 1983 Dec; 117(3):908-15. PubMed ID: 6421289
[TBL] [Abstract][Full Text] [Related]
15. Synthetic low-toxicity muramyl dipeptide and monophosphoryl lipid A replace Freund complete adjuvant in inducing growth-inhibitory antibodies to the Plasmodium falciparum major merozoite surface protein, gp195.
Hui GS; Tam LQ; Chang SP; Case SE; Hashiro C; Siddiqui WA; Shiba T; Kusumoto S; Kotani S
Infect Immun; 1991 May; 59(5):1585-91. PubMed ID: 2019429
[TBL] [Abstract][Full Text] [Related]
16. Plasmodium falciparum: elicitation by peptides and recombinant circumsporozoite proteins of circulating mouse antibodies inhibiting sporozoite invasion of hepatoma cells.
Hollingdale MR; Ballou WR; Aley SB; Young JF; Pancake S; Miller LH; Hockmeyer WT
Exp Parasitol; 1987 Jun; 63(3):345-51. PubMed ID: 2438152
[TBL] [Abstract][Full Text] [Related]
17. Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide.
Vogel FR; Leclerc C; Schutze MP; Jolivet M; Audibert F; Klein TW; Chedid L
Cell Immunol; 1987 Jun; 107(1):40-51. PubMed ID: 2438053
[TBL] [Abstract][Full Text] [Related]
18. Repeating covalent structure and protective immunogenicity of native and synthetic polypeptide fragments of type 24 streptococcal M protein. Mapping of protective and nonprotective epitopes with monoclonal antibodies.
Beachey EH; Seyer JM; Dale JB; Hasty DL
J Biol Chem; 1983 Nov; 258(21):13250-7. PubMed ID: 6415061
[TBL] [Abstract][Full Text] [Related]
19. Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology.
Hayman WA; Toth I; Flinn N; Scanlon M; Good MF
Immunol Cell Biol; 2002 Apr; 80(2):178-87. PubMed ID: 11940119
[TBL] [Abstract][Full Text] [Related]
20. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci.
Bessen D; Fischetti VA
Infect Immun; 1988 Oct; 56(10):2666-72. PubMed ID: 2458320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
